Combination vaccine could reduce number of shots for infants

In a phase III trial, a new combination vaccine was determined to be effective, safe and well-tolerated. The new vaccine is currently under review by the Food and Drug Administration. After approval, the vaccine will be available for incorporation into the routine childhood schedule.